Antimalarial Drugs Market Size, Share, Growth Analysis, By drug class(Global antimalarial drugs industry share from the aryl aminoalcohol compounds segment might grow at a considerable pace by 2032. The number of people suffering from malaria across the world is increasing every year. About 241 million malaria cases were registered across the globe in 2022, with the WHO Africa region continuing to account for a large share of the disease burden. This will encourage people to take antimalarial drugs to prevent the disease infection. With regards to route of administration, antimalarial drugs market value from the oral segment is expected to increase at a significant rate by 2032. There are many advantages associated with this route of administration, such as better patient compliance), By application(The treatment segment is expected to capture a sizeable share of antimalarial drugs market by 2032. Malaria treatments depend on many factors including the species of malaria parasite, intensity of the disease, and the country/region in which the patient contracted the infection. Increasing global mortality rate from malaria might require people to receive proper medication to treat the disease effectively, thereby propelling the market growth.) - Industry Forecast 2024-2031

Antimalarial Drugs Market Insights

Market Overview:

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.